MBP metabolic pharmaceuticals limited

Yes, reluctantly I have to say that the market is not responding...

  1. 5,318 Posts.
    lightbulb Created with Sketch. 253
    Yes, reluctantly I have to say that the market is not responding to this new opportunity with the enthusiasm that I expected - or that the facts seem to warrant.

    I still think that the value of this package AT THE PRESENT TIME, with no new data, is 6 cents per share.

    Obviously, the market is an ass.

    I expected (and still expect) news on one or more of the applications presently under development, but the pace of the acquisition is slower than I expected, and market enthusiasm is also lagging my expectations.

    I still have an expectation that we will see 20 cents in the near to medium term, but I am no longer willing to pin the timing to year's end.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.